Solid Pseudopapillary Neoplasm of the Pancreas with High-Grade Malignant Transformation Involving p16-RB Pathway Alterations.
Journal
Case reports in surgery
ISSN: 2090-6900
Titre abrégé: Case Rep Surg
Pays: United States
ID NLM: 101580191
Informations de publication
Date de publication:
2020
2020
Historique:
received:
01
09
2019
accepted:
30
12
2019
entrez:
12
3
2020
pubmed:
12
3
2020
medline:
12
3
2020
Statut:
epublish
Résumé
Solid pseudopapillary neoplasm (SPN) of the pancreas has generally been regarded as a low-grade malignant tumour that preferentially develops in young women and can have a good prognosis with surgery. Among the few patients who have died from metastatic SPN are mostly those whose tumours harbour an undifferentiated component characterized by diffuse sheets of cells with increased nuclear atypia and proliferative index. We herein report a case of an aggressive, fatal, solid pseudopapillary neoplasm (SPN) of the pancreas in a 63-year-old woman complaining of epigastric pain. Despite having undergone surgical resection for a 10 cm pancreatic mass and multiple liver metastases, the patient later died due to uncontrollable metastases 36 months after the initial surgery. Histological examination showed that the tumour displayed unusual high-grade malignant features, showing diffuse sheets of cells with increased nuclear atypia and proliferative activity, along with conventional low-grade malignant features. The tumour was subsequently recognized as an SPN with foci of high-grade malignant transformation according to the 2010 World Health Organization classification. Immunohistochemical studies revealed that p16-RB pathway alterations contributed to the high-grade malignant transformation. The present case report suggests the necessity for developing diagnostic and treatment methods targeting p16 and RB for high-grade variants of SPN.
Identifiants
pubmed: 32158585
doi: 10.1155/2020/5980382
pmc: PMC7059088
doi:
Types de publication
Case Reports
Langues
eng
Pagination
5980382Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2020 Kodai Tomioka et al.
Déclaration de conflit d'intérêts
None of the authors has any conflict of interest to declare in regard to this study.
Références
J Am Coll Surg. 2009 May;208(5):950-7; discussion 957-9
pubmed: 19476869
Pathol Int. 2017 Oct;67(10):526-530
pubmed: 28851045
Oncogene. 2011 May 5;30(18):2087-97
pubmed: 21297668
J Pathol. 2019 Jan;247(1):123-134
pubmed: 30306561
Arch Pathol Lab Med. 2014 Jul;138(7):974-8
pubmed: 24978926
Am J Surg. 2009 Aug;198(2):210-5
pubmed: 19268906
J Surg Oncol. 2016 Oct;114(5):597-601
pubmed: 27471041
Clin Cancer Res. 2017 Aug 15;23(16):4625-4632
pubmed: 28455360
Am J Surg Pathol. 2005 Apr;29(4):512-9
pubmed: 15767807
Pathol Int. 2017 Apr;67(4):202-207
pubmed: 28208222